• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

    5/8/25 4:47:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CVS alert in real time by email

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.)

    Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary with subsidiaries of Aetna.

    Lastly, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of CVS Caremark Indemnity Ltd. (CVS Caremark Indemnity) (Bermuda). The outlook of these Credit Ratings (ratings) is stable.

    The ratings of Aetna Health & Life Group reflect its balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).

    The rating affirmations for Aetna Health & Life Group reflect the group's strongest level of risk-adjusted capitalization, as measured by its Best Capital Adequacy Ratio (BCAR), and improved operating performance in first-quarter 2025 and expected for full year 2025. Capital and surplus has grown steadily over the past five years and was aided by capital contributions from its parent company, CVS Health, in 2024. Historically, the group has paid large dividends to its parent while maintaining strong capital growth in most years. Investments are managed centrally, and the risk profile of the group's investment portfolio has remained relatively consistent over the past few years. The investment portfolio is primarily composed of investment-grade fixed-income securities, as well as cash and cash equivalents.

    Additionally, the balance sheet strength is supported by adequate liquidity measures, which are strengthened by the group's access to the Federal Home Loan Bank of Boston at the lead entity, ALIC. Aetna Health & Life Group continues to have moderate reinsurance leverage; however, its reinsurance arrangements differentiate Aetna from its health insurance peers. In addition to traditional reinsurance with highly rated carriers, Aetna Health & Life Group maintains a quota share reinsurance agreement with Health Re Inc. and subsequent excess of loss protection by Vitality Re entities.

    Over the past few years, favorable development in the group's net premium has been driven by membership growth in the commercial and Medicare Advantage product lines. However, the group expects a decline in Medicare Advantage and individual exchange membership for 2025. Underwriting earnings in 2024 were challenged due to increased utilization, the unfavorable impact of the decline in the group's Medicare Advantage star ratings for the 2024 payment year, as well as higher acuity in Medicaid. The group's star ratings improved for 2025, as roughly 90% of members are in a 4+ star Medicare Advantage plan, which combined with pricing actions and other initiatives taken should improve profitability in the line of business during the year. Additionally, investment income has been steady over the past five years and is expected to continue to impact overall earnings positively in 2025 and beyond.

    Aetna is one of the nation's leading providers of employee health insurance benefits. Aetna's lines of business are diversified by both product and geography. Furthermore, Aetna maintains a strong market position in the Medicare, Medicaid and commercial markets. The group competes in nearly all U.S. states in both its commercial and government program offerings.

    The ratings of Aetna Health & Life Group reflect the negative impact from its ultimate parent, CVS Health, which has elevated financial leverage and goodwill. Unfavorable underwriting performance in 2024 resulted in capital contributions from CVS Health to its insurance subsidiaries, hindering the parent's plans to de-lever. With earnings expected to improve in 2025, financial leverage should resume a declining trend. Goodwill and intangibles-to-shareholders equity increased over the prior year and exceeded 120% at year-end 2024, as the level of goodwill increased in 2023 driven by the acquisitions of Oak Street Health and Signify Health.

    The ratings of Allina Health reflect its balance sheet strength, which AM Best assesses as adequate, as well as its marginal operating performance, limited business profile, appropriate ERM and the support of the Aetna organization. Allina reported an underwriting loss in 2024 after two straight years of underwriting gains. The underwriting loss was primarily driven by utilization in the Medicare Advantage line. Additionally, earnings are negatively impacted by the amortization of intangible assets, which has resulted in a trend of net losses. In recent years, premium growth has trended favorably in Medicare Advantage products, while commercial premium declined slightly in 2024.

    The ratings of CVS Caremark Indemnity reflect its balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile, appropriate ERM and the support of its parent. The company's market position is largely driven from its parent, CVS Health, as all the business CVS Caremark Indemnity writes or assumes involves CVS Health affiliated entities. The company has a 15% quota share agreement with SilverScript Insurance Company, a CVS Health affiliate, which comprises most of its premium.

    The FSR of A (Excellent) and the Long-Term ICRs of "a" (Excellent) have been affirmed, with stable outlooks for the following members of Aetna Health & Life Group:

    • Aetna Life Insurance Company
    • Aetna Health and Life Insurance Company
    • Aetna Life & Casualty (Bermuda) Ltd.
    • Aetna Health Inc. (a Connecticut corporation)
    • Aetna Health Inc. (a Florida corporation)
    • Aetna Health Inc. (a Georgia corporation)
    • Aetna Health Inc. (a Louisiana corporation)
    • Aetna Health Inc. (a New Jersey corporation)
    • Aetna Health Inc. (a New York corporation)
    • Aetna Health Inc. (a Maine Corporation)
    • Aetna Health Inc. (a Pennsylvania corporation)
    • Aetna Health Inc. (a Texas corporation)
    • Aetna Health Insurance Company
    • Aetna Health Insurance Company of New York
    • Aetna Better Health of Florida, Inc.
    • Aetna Health of California Inc.
    • Aetna Health of Iowa, Inc.
    • Aetna Health of Utah, Inc.
    • Aetna Dental of California Inc.
    • Aetna Dental Inc. (a New Jersey corporation)
    • Aetna Dental Inc. (a Texas corporation)
    • American Continental Insurance Company
    • Accendo Insurance Company
    • Continental Life Insurance Company of Brentwood, Tennessee
    • Coventry Health and Life Insurance Company
    • Aetna Better Health of Michigan, Inc.
    • Aetna Better Health of Missouri, LLC
    • Coventry Health Care of Illinois, Inc.
    • Coventry Health Care of Kansas, Inc.
    • Coventry Health Care of Missouri, Inc.
    • Coventry Health Care of Nebraska, Inc.
    • Coventry Health Care of Virginia, Inc.
    • Coventry Health Care of West Virginia, Inc.
    • First Health Life & Health Insurance Company
    • SilverScript Insurance Company

    This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.

    AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

    Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250508853969/en/

    Jon Housel

    Financial Analyst

    +1 908 882 1898

    [email protected]

    Sally Rosen

    Senior Director

    +1 908 882 2284

    [email protected]

    Christopher Sharkey

    Associate Director, Public Relations

    +1 908 882 2310

    [email protected]

    Al Slavin

    Senior Public Relations Specialist

    +1 908 882 2318

    [email protected]

    Get the next $CVS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS

    DatePrice TargetRatingAnalyst
    10/14/2025$91.00Buy
    Goldman
    8/18/2025$79.00Neutral → Buy
    UBS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    1/30/2025Hold → Buy
    Edward Jones
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    11/18/2024$60.00 → $66.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $CVS
    SEC Filings

    View All

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    11/20/25 4:18:11 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 13F-HR filed by CVS Health Corporation

    13F-HR - CVS HEALTH Corp (0000064803) (Filer)

    10/31/25 4:14:04 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 10-Q filed by CVS Health Corporation

    10-Q - CVS HEALTH Corp (0000064803) (Filer)

    10/29/25 6:34:58 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shulman Douglas H. was granted 1,652 shares, increasing direct ownership by 39% to 5,929 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    11/21/25 5:47:50 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P was granted 1,652 shares, increasing direct ownership by 14% to 13,659 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    11/21/25 5:46:44 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Director Robbins Larry

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    11/21/25 5:45:52 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS Health Names David Joyner Chair of the Board of Directors

    WOONSOCKET, R.I., Nov. 20, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Board, effective January 1, 2026. Following the effective date of this appointment, Michael Mahoney will continue to serve as the Board's Lead Independent Director, and Roger Farah, who is currently serving as Executive Chair of the Board, will continue to serve on the Board. Joyner was named President and CEO of CVS Health in October 2024, and has led significant operational, financial

    11/20/25 4:05:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Pharmacy® introduces Joyward™, a new brand designed to bring the joy of every moment to life

    WOONSOCKET, R.I., Nov. 20, 2025 /PRNewswire/ -- CVS Pharmacy® today announced the launch of Joyward™, a new line of decor, gifts and more to celebrate the joy of every season. Joyward brings together on-trend and high-quality products to help celebrate all of life's moments, big and small. Joyward will continue to evolve in 2026 and beyond with new products to celebrate everything from birthdays and holidays to backyard gatherings, graduations and other milestones. Each collection will introduce trending designs and expanded categories that reflect the many ways customers come

    11/20/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna Launches Leading Edge Conversational AI Navigation

    Embedded assistant revolutionizes how members navigate their health care journeyWOONSOCKET, R.I., Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE:CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience. This represents a paradigm shift, as Aetna continues to transition from the industry's traditional transactional experience to a consumer health experience. Unlike other industry alterna

    11/18/25 11:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded CVS Health from Neutral to Outperform and set a new price target of $82.00

    8/14/25 8:02:24 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    2/19/25 12:35:35 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Financials

    Live finance-specific insights

    View All

    CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

    Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior yearThird quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unitThird quarter Adjusted EPS of $1.60Generated year-to-date cash flow from operations of $7.2 billionOperational Highlights Aetna® receives industry-leading Medicare Advantage Star Ratings resultsLaunch of annual vaccination campaign at CVS Pharmacy® and MinuteClinic® locations nationwideCaremark® closes out another strong selling season with contract wins totaling nearly $6.0 billion and retention in the high nineties

    10/29/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Pharmacy completes acquisition of Rite Aid assets nationwide

    Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I., Oct. 15, 2025 /PRNewswire/ -- CVS Pharmacy today announced the completion of its acquisition of select Rite Aid assets nationwide. In total, the company acquired and is now operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. CVS Pharmacy also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. As a result of the transactions, CVS Pharmacy is pleased to be serving more than nine million former Rite Aid and Bartell Drugs patients.

    10/15/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health to hold third quarter 2025 earnings conference call

    WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

    9/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

    WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

    4/8/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/13/24 5:02:40 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/9/23 11:16:32 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples